Suhaib Hassan

Suhaib Hassan is an accomplished global director with extensive experience in the pharmaceutical industry, focusing on oncology and radiosensitive cancers. Currently serving as the Global Director of Pipeline Growth & Management at Merck Group, Suhaib Hassan has led the development of technologies and commercial assessments for various pipeline assets while providing strategic inputs on multiple technology assessments. Previous roles include Global Director at Novartis, where Suhaib Hassan developed strategic plans for key cancer therapies and contributed to significant product launches. With experience at leading companies such as Novo Nordisk, Roche, and AstraZeneca, Suhaib Hassan has a track record of optimizing launch strategies, advancing digital initiatives, and driving commercialization efforts. Suhaib Hassan holds an MBA from HEC Paris and a Bachelor's degree in Business Studies from Shaheed Sukhdev College of Business Studies.